Biomarkers of glycolysis in NSCLC. RNF180, ring finger protein 180; UGT8, UDP-glycosyltransferase 8; SIX1, sine oculis homeobox homolog 1; TRAF6, TNF receptor-associated factor 6; EHD1, Eps15 homology domain 1; OCT-1, octamer-transcription factor-1; ISLR, leucine-rich repeat; JOSD2, Josephin domain containing 2; PRKACA, protein kinase cAMP-activated catalytic subunit alpha; PFKP, phosphofructokinase; TRIM59, tripartite motif-containing 59; NALP3, NLR family pyrin domain containing 3; CPS1, carbamoyl phosphate synthetase I; PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; PD-1, programmed cell death protein 1; PD-l1, programmed death-ligand 1; OTUB2, OTU deubiquitinase, ubiquitin aldehyde binding 2; DPPA4, developmental pluripotency-associated 4; PINK1, PTEN-induced putative kinase 1; KLF5, factor 5; ALDOA, aldolase A; EGFR, epidermal growth factor receptor; GFPT2, glutamine-fructose-6-phosphate transaminase 2; NQO1, NAD(P)H quinone oxidoreductase 1; PDK1, pyruvate dehydrogenase kinase 1; BARX2, BarH-like homeobox 2; PGC-1alpha, pPARG coactivator 1 alpha; NOX4, NADPH oxidase 4; IL-33, interleukin 33; ENO1, alpha-enolase; BSG, cD147/basigin; KRAS, Kirsten-RAS; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; FBP1, fructose-1,6-bisphosphatase; HIF-1α, hypoxia-inducible factor 1 subunit alpha; Hsp27, heat shock protein 27.